2,2-diethoxy-N,N-bis(pyridin-2-ylmethyl)ethanamine | 863393-85-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2,2-diethoxy-N,N-bis(pyridin-2-ylmethyl)ethanamine
• CAS: 863393-85-5
• 化学式: C₁₈H₂₅N₃O₂
• 分子量: 315.415
• InChiKey: FDSSSLKLYKSVJP-UHFFFAOYSA-N

物化性质

• 沸点：
  414.6±40.0 °C(Predicted)
• 密度：
  1.092±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  23
• 可旋转键数：
  10
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  47.5
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  二甲基吡啶胺 、 2-溴-1,1-二乙氧基乙烷 在 potassium carbonate 、 三乙胺 作用下， 以 DMF (N,N-dimethyl-formamide) 为溶剂， 反应 1.0h， 以64.6%的产率得到2,2-diethoxy-N,N-bis(pyridin-2-ylmethyl)ethanamine
  参考文献：
  名称：

  [EN] TECHNETIUM- AND RHENIUM-BIS(HETEROARYL) COMPLEXES, AND METHODS OF USE THEREOF
  [FR] COMPLEXES DE TECHNETIUM- ET RHENIUM-BIS(HETEROARYLE), ET LEURS PROCEDES D'UTILISATION

  摘要：

  该发明的一个方面涉及放射性核素与各种杂环芳基配体（例如咪唑基和吡啶基配体）形成的配合物，以及它们在临床诊断和治疗应用中的放射性药物中的使用。该发明的另一个方面涉及形成前述配合物一部分的咪唑基和吡啶基配体。还描述了制备放射性核素配合物的方法。该发明的另一个方面涉及基于衍生赖氨酸、丙氨酸和双氨基酸的咪唑基和吡啶基配体，用于通过固相合成方法与小肽结合。此外，该发明涉及使用该发明的配合物来成像哺乳动物体内区域的方法。

  公开号：

  WO2005079865A1

文献信息

• Technetium-And Rhenium-Bis (Heteroaryl) Complexes, And Methods Of Use Thereof
  申请人：Babich John W.

  公开号：US20080025915A1

  公开（公告）日：2008-01-31

  One aspect of the invention relates to complexes of a radionuclide with various heteroaryl ligands, e.g., imidazolyl and pyridyl ligands, and their use in radiopharmaceuticals for a variety of clinical diagnostic and therapeutic applications. Another aspect of the invention relates to imidazolyl and pyridyl ligands that form a portion of the aforementioned complexes. Methods for the preparation of the radionuclide complexes are also described. Another aspect of the invention relates to imidazolyl and pyridyl ligands based on derivatized lysine, alanine and bis-amino acids for conjugation to small peptides by solid phase synthetic methods. Additionally, the invention relates to methods for imaging regions of a mammal using the complexes of the invention.

  本发明的一个方面涉及放射核素与各种杂环配体的复合物，例如咪唑基和吡啶基配体，以及它们在临床诊断和治疗应用中的放射性药物中的使用。本发明的另一个方面涉及形成上述复合物的咪唑基和吡啶基配体。还描述了制备放射核素复合物的方法。本发明的另一个方面涉及基于衍生的赖氨酸、丙氨酸和双胺基酸的咪唑基和吡啶基配体，以通过固相合成方法与小肽结合。此外，本发明涉及使用本发明的复合物成像哺乳动物区域的方法。
• Technetium- and Rhenium-Bis(heteroaryl) Complexes, and Methods of Use Thereof
  申请人：Babich John W.

  公开号：US20100303725A1

  公开（公告）日：2010-12-02

  One aspect of the invention relates to complexes of a radionuclide with various heteroaryl ligands, e.g., imidazolyl and pyridyl ligands, and their use in radiopharmaceuticals for a variety of clinical diagnostic and therapeutic applications. Another aspect of the invention relates to imidazolyl and pyridyl ligands that form a portion of the aforementioned complexes. Methods for the preparation of the radionuclide complexes are also described. Another aspect of the invention relates to imidazolyl and pyridyl ligands based on derivatized lysine, alanine and bis-amino acids for conjugation to small peptides by solid phase synthetic methods. Additionally, the invention relates to methods for imaging regions of a mammal using the complexes of the invention.

  该发明的一个方面涉及放射核素与各种杂环芳基配体（例如咪唑基和吡啶基配体）的配合物，以及它们在临床诊断和治疗应用中的放射性药物中的使用。该发明的另一个方面涉及构成上述配合物一部分的咪唑基和吡啶基配体。还描述了制备放射核素配合物的方法。该发明的另一个方面涉及基于衍生赖氨酸、丙氨酸和双氨基酸的咪唑基和吡啶基配体，以通过固相合成方法与小肽结合。此外，该发明涉及使用所述配合物成像哺乳动物区域的方法。
• Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof
  申请人：Babich John W.

  公开号：US20090148382A1

  公开（公告）日：2009-06-11

  One aspect of the invention relates to complexes of technetium (Tc) and rhenium (Re) with various heteroaromatic ligands, e.g., quinolinyl and isoquinolinyl ligands, and their use in fluorescence and radioimaging for a variety of clinical diagnostic applications, as well as radiopharmaceuticals for therapeutic applications. Another aspect of the invention relates to quinolinyl and isoquinolinyl ligands that form a portion of the aforementioned complexes. Methods for the preparation of the technetium and rhenium complexes are also described. Another aspect of the invention relates to quinolinyl and isoquinolinyl ligands based on derivatized lysine, alanine and bis-amino acids for conjugation to small peptides by solid phase synthetic methods. Additionally, the invention relates to methods for imaging regions of a mammal using the complexes of the invention.
• US7824661B2
  申请人：——

  公开号：US7824661B2

  公开（公告）日：2010-11-02
• [EN] TECHNETIUM- AND RHENIUM-BIS(HETEROARYL) COMPLEXES, AND METHODS OF USE THEREOF<br/>[FR] COMPLEXES DE TECHNETIUM- ET RHENIUM-BIS(HETEROARYLE), ET LEURS PROCEDES D'UTILISATION
  申请人：MOLECULAR INSIGHT PHARM INC

  公开号：WO2005079865A1

  公开（公告）日：2005-09-01

  One aspect of the invention relates to complexes of a radionuclide with various heteroaryl ligands, e.g., imidazolyl and pyridyl ligands, and their use in radiopharmaceuticals for a variety of clinical diagnostic and therapeutic applications. Another aspect of the invention relates to imidazolyl and pyridyl ligands that form a portion of the aforementioned complexes. Methods for the preparation of the radionuclide complexes are also described. Another aspect of the invention relates to imidazolyl and pyridyl ligands based on derivatized lysine, alanine and bis-amino acids for conjugation to small peptides by solid phase synthetic methods. Additionally, the invention relates to methods for imaging regions of a mammal using the complexes of the invention.

  该发明的一个方面涉及放射性核素与各种杂环芳基配体（例如咪唑基和吡啶基配体）形成的配合物，以及它们在临床诊断和治疗应用中的放射性药物中的使用。该发明的另一个方面涉及形成前述配合物一部分的咪唑基和吡啶基配体。还描述了制备放射性核素配合物的方法。该发明的另一个方面涉及基于衍生赖氨酸、丙氨酸和双氨基酸的咪唑基和吡啶基配体，用于通过固相合成方法与小肽结合。此外，该发明涉及使用该发明的配合物来成像哺乳动物体内区域的方法。